Global Project Tests Safe Transport of Precision Therapies by Air

A new logistics project is testing how to safely transport precision therapies across borders. Since November 2025, test shipments of cell and blood samples have flown from Brussels to Dallas. The trials aim to create the first global standard for handling these highly sensitive materials by air.

The Precision Therapy Logistics Gateway (PTLG) project is leading the effort. Its goal is to develop a reliable system for moving precision therapies quickly and securely. These therapies demand strict control over temperature, speed, and tracking to stay effective.

The first test shipments left Brussels Airport, where they cleared customs and were stored in temperature-controlled zones. From there, they were placed in refrigerated containers for the flight to Dallas. On arrival, the samples were taken to BioLabs Pegasus Park for inspection before returning to Belgium.

So far, 50 test shipments have been planned to gather more data and confirm the process works repeatedly. Brussels Airport, along with the Science Park University of Antwerp and at.las, is managing the trials. Their experience with time- and temperature-sensitive pharmaceuticals helps guide the project.

The PTLG team is also checking for weaknesses in current logistics methods. They want to adjust air cargo systems to handle precision therapies on a larger scale. Results from these tests are expected by mid-2026.

The successful early shipments mark progress toward a standardized global logistics framework. If validated, the new protocol could ensure precision therapies reach patients safely and efficiently. Further trials will determine whether the system can scale up for wider use.